. 2015 Jan 7;4(1):18–26. doi: 10.1530/EC-14-0051
This work is licensed under a Table 1.
Prevalence of VPAC2 receptors in selected human tumours.
| Tumour type (n) | VPAC2a (n) |
|---|---|
| Gastric cancer (20) | 12 |
| Gastrointestinal stromal tumours (4) | 2 |
| Pancreatic ductal adenocarcinoma (10) | 6 |
| Small-cell lung carcinoma (5) | 4 |
| Lung adenocarcinoma (5) | 1 |
| Squamous cell carcinoma of the lung (46) | 2 |
| Sarcoma (19) | 13 |
| Pleomorphic sarcoma (2) | 2 |
| Leiomyosarcoma (4) | 1 |
| Rhabdomyosarcoma (46) | 3 |
| Liposarcoma (4) | 2 |
| Angiosarcoma (2) | 2 |
| Osteosarcoma (4) | 3 |
| Thyroid carcinoma (2) | 2 |
| Breast cancer (10) | 4 |
| Ovarian carcinoma (12) | 3 |
| Cervical carcinoma (13) | 4 |
| Urinary bladder carcinoma (8) | 0 |
| Prostate cancer (7) | 0 |
| Neuroendocrine tumours (23) | 5 |
| Pituitary adenoma, growth-hormone-producing (21) | 10 |
| Pheochromocytoma (5) | 0 |
a
A tumour sample was considered positive if at least 30% of tumour cells exhibited a moderate-to-strong staining of the plasma membrane.